Microbiome Connect is the world leading business focused summit for microbiome drug development. We accelerate pipeline development and enable commercialization of therapeutics by uniting strategic partners and platforming the latest R&D breakthroughs. This is your opportunity to unlock investment opportunities, understand regulatory landscapes, and streamline manufacturing in the APAC region.VIEW THE EVENT SCHEDULE
Join a like-minded community of 300 scientists and entrepreneurs as passionate about the microbiome as you are. Microbiome Connect was born with the simple mission to bring innovative products to patients, and we bring together experts approaching this challenge from every angle. Together, we provide a platform that allows you to unleash the full therapeutic power of the microbiome.
In recent times, a number of prominent collaborations between pharmaceutical companies and AI firms have emerged, signalling the growing importance of validating and enhancing these methodologies. As technology continues to advance, the AI Driven Drug Discovery Summit serves as a platform to showcase innovative approaches for effectively incorporating cutting-edge AI technologies into the ever-expanding realm of datasets.In this rapidly evolving landscape, it has become imperative to determine where and how AI can provide the most value. By bringing together leaders from the pharmaceutical, biotechnology, AI technology, and academic sectors, this forum offers an invaluable opportunity to develop a well-defined strategic vision with ambitious goals for harnessing AI's potential to optimize the process of drug discovery.
The Advanced Wound Care Summit USA is the only industry-led forum focused on uniting industry leaders to foster strategic partnerships, drive innovation, and unlock the potential of wound care products and services.Find out how C-level Executives, VPs, and Directors of R&D are tackling the most pressing industry challenges and seizing new growth opportunitiesIncluding:Jaideep Banerjee, Lead Medical Science Liaisons and Clinical Strategy, Smith & NephewEmma Wright, Chief Medical Officer, MolnlyckeCaroline Fife, Chief Medical Officer, IntellicureLisa Gould, Plastic Surgeon, South Shore HospitalAn opportunity to address shared challenges around innovative product development, build meaningful partnerships, and sharpen their R&D and commercial strategies. Uncover how leading figures are leveraging novel clinical trial designs, addressing reimbursement challenges surrounding skin substitute products, and progressing next-generation diagnostic innovations this April 2024.JOIN US IN 2024
It’s a chance for senior executives to address shared challenges around innovative therapeutic development, build meaningful partnerships, and sharpen their R&D and commercial strategies. Bringing together the whole microbiome therapeutics ecosystem – from investors and large pharmaceutical companies through to the most pioneering biotechs, academic institutions and solution providers – it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.With recent approvals for C. difficile from Rebiotix a Ferring Company, Seres Therapeutics and BiomeBank, Microbiome Connect highlights the next wave of cutting-edge science poised to impact this field – with sessions on preclinical and clinical data alongside discussions around manufacturing and diagnostic development.
Advancing the development and commercialization of nutritional and therapeutic solutions from lab to label to improve the health of livestock and companion animalsWelcome to the 5th Annual industry-leading conference on the Animal Microbiome, where you will hear about the cutting-edge research taking place in the use of feed additives and supplements to improve companion and production animal gut health through effective microbiome manipulation.The event will focus on bringing the latest concepts and techniques in microbiome modulation being used across industry and research groups to provide solutions in: Improving feed efficiency through microbiome modulation; Metagenomic, metatranscriptomic and metabolomic analysis techniques; Disease prevention through the microbiome; Understanding host-microbe interactions; Innovations in nutrition through ingredients improvements; and Bringing products to market for the animal microbiomeYou will have the opportunity to join the exclusive community of Animal Microbiome researchers to network and learn from leading experts in animal nutrition and health in this exciting field. Across 2 content packed days, our expert speakers will converge to discuss microbiome modulation strategies and how best this research can be applied in product development – this is not one to miss!
Join us for the return of Phage Futures Europe, this November 2021 in Brussels, as we continue all-important discussions on translating new phage-based applications into clinical studies and beyond. Network and learn from multinational pharma, emerging biotechs, leading academics, investment representatives and regulatory bodies to discover how you can be at the forefront of the developing phage therapy market.Introducing face-to-face interactions once again, Phage Futures Europe will help you maximise networking and commercial development with key industry players such as GSK, BiomX, Contrafect and more. This year, we discuss the viability of phage derived lysines in therapy, assess the therapeutic application of natural phages vs engineered phages and explore the clinical data surrounding the magisterial and compassionate use of phages in Europe. Bacteriophages have seen continued investment and have adapted to global challenges, introducing commercial and marketable prospects for phage application. Phage Futures Europe explores the commercial applications of phages in poultry, aquaculture, biocontrol and skin microbiome, providing insights into the global design of phage products and acquiring pharmaceutical partnerships.
COURTYARD BY MARRIOTT, BOSTON DOWNTOWN BOUTIQUE HOTEL
Love the skin you’re in? How about the bugs on it?Over the six years we’ve run Microbiome Connect: Skin, the field has changed drastically. In a short period, the field has gone from fringe to mainstream, from quantifying the size of bacterial populations to understanding their function. As the field continues to commercialize, it is time to ask how this research can benefit consumers. How can the skin microbiome be leveraged as a source of biomarkers, as a therapeutic modality, as an understandable term to consumers?Join us in Boston for a two-day face-to-face event, attended in the past by the likes of P&G, Jackson Laboratory, and the FDA. Unravel the function of the skin microbiome and apply the latest findings to your future products. See you in November!Here’s a sneak peek of some key takeaways:Establish skin microbiome friendly hygiene products to meet consumer demands related to the pandemic, with Codex Beauty and SanexFind out how to maintain regulatory standards and avoid litigation around claims with Q&A and presentations from FDA and NADDiscover how to use functional prebiotics to feed beneficial bacteria and increase product development price efficiency and convenience with Cybele Microbiome and Colgate PalmoliveTap into personalized skincare with pore specific Cutibacterium acnes data and analytics from Tami Lieberman and DermalaLeverage phage, LBP and autologous bactherapeutics to target skin disease with AOBiome, Azitra, Matrisys, BiomX and more"This event is a unique gathering of individuals from academia and industry who are collaborating to advance microbiome science. Kisaco has gone out of their way to include speakers and perspectives not found elsewhere. I look forward to attending again" KC Communications Group
Courtyard by Marriott, Boston Downtown Boutique Hotel
This is the first-ever event solely dedicated to the oral microbiome. At Microbiome Connect: Oral, attendees will learn the latest scientific & academic research on the role that the microbes in your mouth have on human health and disease with leading academics such as Marcelo Freire, Associate Professor J. Craig Venter Institute, Purnima Kumar, Professor, Ohio State University, and many more.The event will delve into study details of periodontal & systematic disease, caries, pre-and-pro biotics, personalized oral care diseases, and arginine's role on the oral microbiome with Dr Maria Ryan, Chief Clinical Officer at Colgate-Palmolive.Meet innovative start-ups like Danny Grannick, CEO & Founder of Bristle Health, Brian Klein, BrickBuild Therapeutics and Mark Burhene, Ask The Dentist, who are driving cutting-edge research and technological product advancements in oral care.Whether it's finding a new funding lead for your oral microbiology research, connecting with the industry for oral-related product propositions, or perhaps you are just interested in learning more about the oral microbiome. If you are responsible or involved in oral health, this is for you.
Welcome to the Microbiome Consumer Nutrition CongressThe global probiotics market is expected to be worth $64 Bn by 2024, an increase of $20bn from 2017. Rising consumer consciousness around personal healthcare and diet coupled with substantial improvements in R&D is fueling a new wave of products that promote human gut health and wellbeing. Whether you’re developing foods, beverages, nutritional supplements, pre- / pro- biotics or infant formulas, join our network of leading nutrition and consumer goods companies, food and nutritional supplement start-ups, ingredients suppliers, formulation experts, entrepreneurs and leading academics to address the challenges and opportunities of developing the next generation of gut health products.The Microbiome Consumer Nutrition Congress connects science and business in the pre-/pro-biotic and microbiome fields to transform microbiome R&D into successful and effective consumer products. Also on-site will be our 2nd Skin Microbiome West Coast Congress, individual as well combined tickets will be available.
The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.Join 250+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler applicationCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiomeConsumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiomeClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeuticsCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed productsRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic productWith an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!
The Microbiome Invest Congress 2018 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
The Animal Microbiome Congress USA brings together leading veterinary researchers, innovative biotechnology companies, feed and strain manufacturers, animal breeders and producers, pharmaceutical companies, regulatory bodies, and cutting-edge solution providers to understand the latest research focusing on manipulating the animal microbiome, form successful product development strategies, and facilitate collaborations and business partnering.Techniques and products that manipulate the animal microbiome are set to be the next frontier in superior disease therapeutics, diagnostics, and nutrition in livestock, companion animals, and aquaculture. The conference will showcase unpublished data, new technologies, and translational case studies presented by leading academic and industry experts. Our ‘MEETING MOJO’ platform will allow you to schedule meetings across the two conference days to facilitate future collaborations and business partnering.
Welcome to the 3rd Annual North America Microbiome Congress!The 3rd Annual North America Microbiome Congress in San Diego, by Kisaco Research, has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require an insight into the latest microbiome research, clinical trials and collaborative partnerships.With a focus on 5 microbiome niches such as the gut, lung, oral, skin and vaginal- we invite you to join us for 3 days of intense learning, mind-sharing and networking opportunities designed to encourage meaningful connections. In addition, we will be hosting poster sessions for PhD students to provide opportunities for all scientists to learn about state-of-the-art research methods and clinical protocols for conducting microbiome work.Meet and learn from industry leadersConsider the practical aspects of promoting effective partnershipsLearn from the latest unpublished dataNetwork with top academics and clinicians in the field
The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.
